DE69324820D1 - Stabil transformierte säugertierzellen, die eine geregelte, entzündliche cyclooxygenase exprimieren - Google Patents

Stabil transformierte säugertierzellen, die eine geregelte, entzündliche cyclooxygenase exprimieren

Info

Publication number
DE69324820D1
DE69324820D1 DE69324820T DE69324820T DE69324820D1 DE 69324820 D1 DE69324820 D1 DE 69324820D1 DE 69324820 T DE69324820 T DE 69324820T DE 69324820 T DE69324820 T DE 69324820T DE 69324820 D1 DE69324820 D1 DE 69324820D1
Authority
DE
Germany
Prior art keywords
express
regulated
cyclooxygenase
inflammable
stably transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69324820T
Other languages
English (en)
Other versions
DE69324820T2 (de
Inventor
Donald Young
Michael O'banion
Virginia Winn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Application granted granted Critical
Publication of DE69324820D1 publication Critical patent/DE69324820D1/de
Publication of DE69324820T2 publication Critical patent/DE69324820T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/99—Miscellaneous (1.14.99)
    • C12Y114/99001—Prostaglandin-endoperoxide synthase (1.14.99.1), i.e. cyclooxygenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69324820T 1992-09-22 1993-09-22 Stabil transformierte säugertierzellen, die eine geregelte, entzündliche cyclooxygenase exprimieren Expired - Fee Related DE69324820T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94978092A 1992-09-22 1992-09-22
US98383592A 1992-12-01 1992-12-01
US3414393A 1993-03-22 1993-03-22
US5436493A 1993-04-28 1993-04-28
PCT/US1993/009167 WO1994006919A2 (en) 1992-09-22 1993-09-22 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase

Publications (2)

Publication Number Publication Date
DE69324820D1 true DE69324820D1 (de) 1999-06-10
DE69324820T2 DE69324820T2 (de) 2000-01-13

Family

ID=27488184

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69324820T Expired - Fee Related DE69324820T2 (de) 1992-09-22 1993-09-22 Stabil transformierte säugertierzellen, die eine geregelte, entzündliche cyclooxygenase exprimieren

Country Status (9)

Country Link
EP (1) EP0667911B1 (de)
JP (3) JPH08501690A (de)
AT (1) ATE179756T1 (de)
AU (1) AU688282B2 (de)
CA (1) CA2144742A1 (de)
DE (1) DE69324820T2 (de)
HK (1) HK1013106A1 (de)
NZ (1) NZ256776A (de)
WO (1) WO1994006919A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
AU6029396A (en) * 1995-06-07 1996-12-30 University Of Rochester Mammalian prostaglandin h synthase-2
US6160108A (en) * 1995-10-06 2000-12-12 President And Fellows Of Harvard College Platelet activation protein
AU6606500A (en) * 1999-08-06 2001-03-05 G.D. Searle & Co. Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2)
DE60042456D1 (de) * 1999-10-05 2009-08-06 Japan Science & Tech Agency Testverfahren bezüglich der fettzellen und der dickleibigkeit, welches ein nicht-menschliches tier benutzt, dass ein menschliches h-pgds gen überexprimiert
WO2002066635A1 (fr) * 2001-02-23 2002-08-29 Gencom Corporation Animal transgenique possedant un gene du metabolisme des medicaments et utilisation correspondante
CN1821423B (zh) * 2005-08-19 2012-07-25 凯惠科技发展(上海)有限公司 一种抗关节炎药物细胞靶标筛选系统及筛药的方法
JP5641232B2 (ja) * 2010-11-24 2014-12-17 石川県公立大学法人 オゴノリ由来のシクロオキシゲナーゼの遺伝子及び該遺伝子を利用するプロスタグランジン類生産方法

Also Published As

Publication number Publication date
CA2144742A1 (en) 1994-03-31
HK1013106A1 (en) 1999-08-13
WO1994006919A2 (en) 1994-03-31
WO1994006919A3 (en) 1994-05-11
EP0667911A1 (de) 1995-08-23
JPH08501690A (ja) 1996-02-27
NZ256776A (en) 1997-10-24
JP2005068157A (ja) 2005-03-17
AU5165293A (en) 1994-04-12
ATE179756T1 (de) 1999-05-15
AU688282B2 (en) 1998-03-12
JP2004105186A (ja) 2004-04-08
DE69324820T2 (de) 2000-01-13
EP0667911B1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
GR3022358T3 (en) Beta retinoic acid response elements compositions and assays
DE69324820D1 (de) Stabil transformierte säugertierzellen, die eine geregelte, entzündliche cyclooxygenase exprimieren
AU1909695A (en) Transgenic non-human mammals with progressive neurologic disease
ES2180538T3 (es) Suministro dirigido de vector virico a celulas de mamiferos.
DE3853474D1 (de) Vektor zur integrationsstellenunabhängigen genexpression in säugetier-wirtszellen.
BR9510408A (pt) Aperfeiçoamento na ou relativos á função endometrial
DE69317270T2 (de) Optische schaltvorrichtung
IT8221889A0 (it) Lega di zirconio-vanadio-ferro stabilizzata con ossigeno.
White Prospects for sexing mammalian sperm edited by Rupert P. Amman and George E. Seidel, Jr.; 288 pages; Cloth-$32.50, Paper-$22.50. Available from Colorado Associated University Press, 1338 Grandview Avenue, Box 480, University of Colorado, Boulder, Colorado, 80309
DE69227589T2 (de) Ecdysteroid-abhängige gen regulierung in säugetier-zellen
AU583471B2 (en) Hla d typing assay
Chan et al. A hydroperoxy-epidioxide from the autoxidation of a hydroperoxide of methyl linolenate
WO2001068831A3 (en) Effective nuclear reprogramming in mammals
DK0851028T3 (da) Immortaliseret human hornhindeepitalcellelinje
EP0350052A3 (de) Transgene Tiere, die mit einem Plasmid mit autonomer Replikationssequenz transformiert sind
ATE297999T1 (de) Dna expression in transfizierten zellen und testverfahren in transfiziereen zellen
GB908808A (en) Waveguide coupling arrangement
Kaizu Studies on the Consumers Motives of Purchase (Part I)
WO2002066610A3 (en) Hepp, a novel gene with a role in hematopoietic and neural development
IT1151598B (it) Carro merci coperto, le cui pareti laterali si compogono rispettivamente di almento tre parti parietali, mobili
WO1999063052A3 (en) Bigenic mouse models and assays to identify proliferation and differentiation regulators
Vaughan First-aid for public libraries
VAN et al. Optinen kytkentälaite
ES8303985A1 (es) Perfeccionamientos en los soportes de fijacion de tanques montados sobre vehiculos
JPS57130841A (en) Concentratedly arranged construction of switches

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee